Immupharma PLC Rodman and Renshaw Conference
07 September 2012 - 8:12PM
RNS Non-Regulatory
TIDMIMM
Immupharma PLC
07 September 2012
FOR IMMEDIATE RELEASE 7 SEPTEMBER 2012
RNS REACH
ImmuPharma to Present at
Rodman and Renshaw Annual Global Investment Conference, New
York
Tuesday 11 September 2012
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, is pleased to
confirm that it will be presenting at the Rodman and Renshaw Annual
Global Investment Conference on Tuesday 11 September 2012 at the
Waldorf Astoria in New York City. Tracy Weimar, Vice President,
Operations and Finance will present an overview of ImmuPharma at
16:55 PM Eastern Time.
If you would like to arrange a one to one meeting with
ImmuPharma during this conference between 10-12 September, please
do not hesitate to contact either Tracy Weimar or Lisa Baderoon,
Head of Investor Relations.
Ends
For further information please contact:
ImmuPharma PLC (www.immupharma.com)
Tracy Weimar, Vice President, Operations
and Finance
tracy.weimar@immupharma.com +44 020 7152 4080
Lisa Baderoon, Head of Investor Relations
Lisa.baderoon@immupharma.com +44 7721 413 496
Buchanan + 44 20 7466 5000
Mark Court
Notes to Editors
ImmuPharma
ImmuPharma is focusing on developing novel medicines with high
sales potential in specialist markets with serious unmet need.
ImmuPharma has five drug candidates in development, two platform
technologies and approximately 70 patents. The Company's most
advanced drug candidate, Lupuzor(TM) a potential blockbuster drug
for Lupus, a chronic autoimmune disease has recently received the
approval from the US FDA to enter phase III with a Special Protocol
Assessment and "Fast Track" designation. ImmuPharma was founded and
is led by a commercially focused Board and management team with
extensive experience. www.immupharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRASSFFSWFESEFU
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024